Cargando…
Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia
BACKGROUND: Releasing drug molecules at the targeted location could increase the clinical outcome of a large number of anti-tumor treatments which require low systemic damage and low side effects. Nano-carriers of drugs show great potential for such task due to their capability of accumulating and r...
Autores principales: | Simon, Timea, Tomuleasa, Ciprian, Bojan, Anca, Berindan-Neagoe, Ioana, Boca, Sanda, Astilean, Simion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666845/ https://www.ncbi.nlm.nih.gov/pubmed/26625890 http://dx.doi.org/10.1186/s11671-015-1154-2 |
Ejemplares similares
-
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
por: Petrushev, Bobe, et al.
Publicado: (2016) -
In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice
por: Berce, Cristian, et al.
Publicado: (2016) -
Long Non-coding RNAs in Myeloid Malignancies
por: Zimta, Alina-Andreea, et al.
Publicado: (2019) -
Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
por: Dobrowolski, Jerome, et al.
Publicado: (2019) -
In Vitro Structural and Functional Evaluation of Gold Nanoparticles Conjugated Antibiotics
por: Saha, Biswarup, et al.
Publicado: (2007)